Idioma:

1 alpha,25-dihydroxyvitamin D3 increases TGF beta 1 binding to human osteoblasts

Nagel, David ; Kumar, Rajiv

Biochemical and biophysical research communications, 2002-02, Vol.290 (5), p.1558-1563 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Enviar para

Título:
1 alpha,25-dihydroxyvitamin D3 increases TGF beta 1 binding to human osteoblasts
Autor: Nagel, David ; Kumar, Rajiv
Assuntos: Activin Receptors, Type I - biosynthesis ; Activin Receptors, Type I - genetics ; Animals ; Calcitriol - pharmacology ; Cell Division - drug effects ; Cell Division - genetics ; Cell Line, Transformed ; Cells, Cultured ; Fetus ; Growth Inhibitors - pharmacology ; Humans ; Mice ; Osteoblasts - cytology ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Protein Binding - drug effects ; Protein-Serine-Threonine Kinases ; Receptors, Transforming Growth Factor beta - biosynthesis ; Receptors, Transforming Growth Factor beta - genetics ; RNA, Messenger - biosynthesis ; Transcription, Genetic - drug effects ; Transforming Growth Factor beta - metabolism ; Transforming Growth Factor beta1 ; Up-Regulation - drug effects ; Up-Regulation - genetics
É parte de: Biochemical and biophysical research communications, 2002-02, Vol.290 (5), p.1558-1563
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: 1alpha,25-Dihydroxyvitamin D3 (1alpha,25(OH)2D3) increases the binding of transforming growth factor beta1(TGF beta1) via TGF beta receptors to the surface of human osteoblasts. The increase in TGF beta receptors induced by 1alpha,25(OH)2D3 is dependent on increases in TGF beta secretion induced by 1alpha,25(OH)2D3, since antibodies directed against TGF beta block the increase in TGF beta1 binding. The increase in TGF beta type I and II receptors on cell surfaces following 1alpha,25(OH)2D3 treatment is associated with increases in receptor mRNA concentrations. Increases in receptor mRNA concentrations following 1alpha,25(OH)2D3 treatment are not due to changes in receptor gene transcription. The role of TGF beta receptors, in mediating the growth responses to 1alpha,25(OH)2D3 is demonstrated by showing that osteoblasts which express dominant negative, kinase-deficient TGF beta type II receptors, fail to respond to the growth-inhibitory effects of 1alpha,25(OH)2D3. An increase in TGF beta receptor expression is important in mediating 1alpha,25(OH)2D3-associated changes in the growth rate of osteoblasts.
Editor: United States
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

1 alpha,25-dihydroxyvitamin D3 increases TGF beta 1 binding to human osteoblasts

Nagel, David ; Kumar, Rajiv

United States

Buscando em bases de dados remotas. Favor aguardar.